Radiopharmaceutical firm Pentixapharm announced its acquisition of Glycotope’s target discovery business, including a portfolio of oncology antibodies, laboratories, and associated assets. Currently owned by the Eckert & Ziegler Group, Pentixapharm will soon become a separate company. The firm is developing treatments for diseases like CNS lymphoma and primary aldosteronism.
Android users bombarded with unskippable ads
Security experts have found a wide-ranging ad fraud network named Kaleidoscope that targets Android users and delivers unsolicited ads. Unlike some other scams, Kaleidoscope operates
